refers to the immediate-release formulation of Adderall containing 30 mg of mixed amphetamine salts. Adderall IR is a central nervous system stimulant prescribed primarily for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy.
-
Adderall combines four amphetamine salts: dextroamphetamine sulfate, amphetamine sulfate, dextroamphetamine saccharate, and amphetamine aspartate.
-
The 30 mg immediate-release (IR) tablet delivers the active ingredients rapidly after ingestion, providing quick onset of therapeutic effects.
-
The IR formulation is typically taken multiple times per day, spaced 4 to 6 hours apart, depending on medical guidance.
-
Treatment of ADHD to improve focus, attention, and impulse control.
-
Management of narcolepsy to reduce excessive daytime sleepiness.
-
Increases concentration, alertness, and cognitive control.
-
Enhances wakefulness and reduces fatigue.
-
May induce euphoria at higher doses.
-
Physical effects include increased heart rate, faster reaction times, and reduced appetite.
-
The 30 mg IR tablet is usually prescribed for patients requiring higher doses or those who have developed tolerance to lower doses.
-
Taken orally, typically 1 to 3 times daily, as directed by a healthcare provider.
-
Should be swallowed whole with water.
-
Avoid taking late in the day to prevent insomnia.
-
Adderall is a Schedule II controlled substance with potential for abuse and dependence.
-
Not recommended for patients with a history of cardiovascular disease, hypertension, hyperthyroidism, glaucoma, or severe anxiety.
-
Avoid use with monoamine oxidase inhibitors (MAOIs) or within 14 days of stopping MAOIs due to risk of hypertensive crisis.
-
Possible side effects include insomnia, dry mouth, loss of appetite, anxiety, increased heart rate, and elevated blood pressure.
-
Monitor for signs of psychosis or circulation problems.
Reviews
There are no reviews yet.